Navigation Links
Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
Date:3/11/2013

Milwaukee, WI (PRWEB) March 11, 2013

The Clinical Immunology Society (CIS) is pleased to announce that Dr. Vincent Bonagura has been selected to serve as the new Editor-in-Chief of the Journal of Clinical Immunology (JoCI) for a five-year term beginning February 1, 2013. Dr. Bonagura is the Chief of the Division of Allergy and Immunology and the Jack Hausman Professor of Pediatrics at the Alexandra and Steven Cohen Children's Medical Center of the North Shore-Long Island Jewish Health System in New York, where he also directs the Jeffrey Modell Foundation Diagnostic Center and the Laboratory of Host Defense. He is also Professor of Molecular Medicine at the Feinstein Institute for Medical Research at North Shore - Long Island Jewish Health System. His research interests include virus infections, autoimmunity and primary immune deficiency; and editorial experience has been with the Annals of Allergy and Immunology, Clinical and Diagnostic Laboratory Immunology, and Clinical Immunology.

"We're very excited to have Dr. Bonagura involved with the journal and I'm certain that under his leadership, we will continue to advance the visibility and reputation of the JoCI and CIS," said CIS President, Lawrence B. Schwartz, MD PhD.

In addition, Dr. Jean-Laurent Casanova has accepted the position of Deputy Editor. Jean-Laurent Casanova, MD PhD received his medical degree from the Université Paris Descartes in 1987. After receiving training at the Pasteur Institute in Paris and the Ludwig Institute for Cancer Research in Lausanne, Switzerland, he received his PhD in immunology from the Université Pierre et Marie Curie in 1992. Following a residency in pediatrics, he completed a clinical fellowship in the pediatric immunology-hematology unit of the Necker Medical School in Paris. In 1999, he was appointed a professor of pediatrics at Necker, where, with Dr Laurent Abel, he cofounded and co-directed the Laboratory of Human Genetics of Infectious Diseases. In 2008, he was appointed a professor at The Rockefeller University in New York.

"I am honored that I have been selected by CIS to lead the journal and I am extremely pleased that Dr. Casanova will serve as Deputy Editor," said Dr. Bonagura. "I would also like to thank Drs. Tom Fleisher and Kathleen Sullivan for paving the way for me to build on what they started two years ago when CIS took over the journal."

The Journal of Clinical Immunology is an international journal published eight times per year that helps researchers and academic clinicians keep current on investigative basic immunology and diseases related to the immune system. This well-established journal publishes articles on basic, translational, and clinical studies in all aspects of immunology, including animal models of human diseases. The 2011 impact factor is 3.077.

CIS, established in 1986, is the key interdisciplinary organization for the field of clinical immunology and is devoted to fostering developments in the science and practice of human immunology. CIS is an international professional organization which includes more than 600 clinicians, investigators, and trainees; the CIS Journal, Journal of Clinical Immunology; CIS School, e.g., Summer School in Primary Immune Deficiencies; and an Annual Meeting. For more information on CIS, please visit http://www.clinimmsoc.org.

###

Read the full story at http://www.prweb.com/releases/2013/3/prweb10514081.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. An Evaluation of Clinical Trial Quality in Russia and Ukraine, new webinar hosted by Xtalks
2. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
3. Macrogen Corp. Announces the Inception of Macrogen Clinical Laboratory (MCL)
4. PhUSE Announces Open Source Repository of Clinical Trial Informatics Analysis Code
5. QIAGEN Unveils Sample-to-Result Next-Generation Sequencing Workflow Designed for Clinical Research and Diagnostics
6. NeoClinical Launches Neo PayPerPatient Clinical Trial Recruitment
7. Eastern Clinical Trials Russia CRO Passes EMA Inspection
8. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
9. Galectin-3 Assessed as a Biomarker of Heart Failure: Key Clinical Trial Findings Published by Dove Medical Press
10. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
11. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... There is no saying when ... relentless pressures in pricing and lack in consumer confidence. ... though - numerous opportunities are up for grabs but ... presents four names in this sector: Portola Pharmaceuticals Inc. ... VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... ... 2016 , ... Tech Coast Angels (TCA) today announced that the ... the annual ACA Summit last week in Philadelphia. , The award recognizes ... angel groups. It is the highest honor available for an early-stage company to receive ...
(Date:5/18/2016)... , May 18, 2016 The Biotech ... does not mean that there are no opportunities ahead. Today, ... Inc. (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... ), and Ophthotech Corp. (NASDAQ: OPHT ). Sign ... at: http://www.activewallst.com/ Threshold Pharmaceuticals ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
Breaking Biology News(10 mins):